Drugs / Hyperbaric prilocaine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02973048 Comparator | Mar → Nov 2018 | hypotensive disorder | Centre Hospitalier Universitaire Saint Pierre | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hyperbaric prilocaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02973048 ↗ |
| Route | Intrathecal | “The dose of 50 mg of hyperbaric prilocaine will be administered to one of two groups intrathecally” NCT02973048 ↗ |